5-Oxo-eicosatetraenoic acid

From WikiMD's WELLNESSPEDIA


Chemical structure of 5-Oxo-eicosatetraenoic acid

5-Oxo-eicosatetraenoic acid (5-oxo-ETE) is a potent eicosanoid that plays a significant role in the immune system and inflammation. It is a metabolite of arachidonic acid, a polyunsaturated fatty acid that is a key component of cell membranes and a precursor to various bioactive lipid mediators.

Biosynthesis[edit]

5-Oxo-ETE is synthesized from 5-hydroxyeicosatetraenoic acid (5-HETE) through the action of the enzyme 5-hydroxyeicosanoid dehydrogenase (5-HEDH). This conversion occurs primarily in leukocytes, which are white blood cells involved in the body's immune response. The production of 5-oxo-ETE is often stimulated by inflammatory signals, making it an important mediator in the body's response to injury and infection.

Biological Functions[edit]

5-Oxo-ETE is known to be a powerful chemoattractant for various types of leukocytes, including neutrophils, eosinophils, and monocytes. It plays a crucial role in the recruitment of these cells to sites of inflammation, where they can combat pathogens and facilitate tissue repair. Additionally, 5-oxo-ETE has been implicated in the pathophysiology of asthma and other allergic conditions due to its ability to attract eosinophils, which are key players in allergic inflammation.

Receptor Interaction[edit]

The biological effects of 5-oxo-ETE are mediated through its interaction with a specific G protein-coupled receptor known as the OXE receptor (also referred to as OXER1). This receptor is expressed on the surface of various immune cells and is responsible for transducing the signals that lead to cell migration and activation in response to 5-oxo-ETE.

Clinical Significance[edit]

Due to its role in inflammation and immune cell recruitment, 5-oxo-ETE is a target of interest in the development of new therapeutic agents for inflammatory diseases. Inhibitors of 5-oxo-ETE synthesis or function could potentially be used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other inflammatory disorders.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=5-Oxo-eicosatetraenoic_acid&oldid=6622564"